Hot Flashes & Night Sweats
Systemic hormone therapy is the most effective treatment for bothersome vasomotor symptoms in appropriate candidates.
At Surrey Women’s Clinic, we provide individualized menopause and hormonal care, helping women understand whether hormone therapy may be appropriate for their symptoms, health history and goals.
Menopause hormone therapy can be highly effective for appropriate women, but it is not one medication, one dose or one risk profile. Treatment decisions depend on symptoms, age, time since menopause, whether the uterus is present, medical history and personal priorities.
The Menopause Society states that hormone therapy remains the most effective treatment for vasomotor symptoms such as hot flashes and night sweats and is also effective for GSM. The balance of benefits and risks varies by individual and by the type, dose, route and duration of treatment.
Systemic hormone therapy is the most effective treatment for bothersome vasomotor symptoms in appropriate candidates.
When sleep problems are driven by hot flashes or night sweats, improving vasomotor symptoms may improve sleep.
Local vaginal therapy may be appropriate when symptoms are primarily genitourinary.
When pain is related to GSM or low-estrogen tissue changes, hormonal treatment may be part of the plan.
The decision to use systemic therapy should consider the overall symptom burden and health context.
Hormone therapy can prevent bone loss and fracture while it is being used, though it is not prescribed solely from a website checklist.
Systemic hormone therapy circulates throughout the body and is typically used for broader menopause symptoms such as hot flashes. Low-dose vaginal estrogen primarily targets local genitourinary tissue. Patients with a uterus generally require adequate endometrial protection when systemic estrogen is used.
The more useful question is whether a particular woman is an appropriate candidate for a particular hormone regimen for a particular symptom. Modern menopause care emphasizes individualized benefit-risk assessment and periodic re-evaluation rather than blanket rules.
The right plan depends on clinical assessment, health history, severity, goals and treatment suitability. These are possible pathways—not a promise that every option is appropriate for every patient.
Systemic therapy may be used for vasomotor symptoms. Women with a uterus generally require endometrial protection with an appropriate progestogen.
When symptoms are primarily vaginal or urinary, local therapy may address tissue symptoms with lower systemic exposure than systemic therapy.
Some women cannot or prefer not to use hormone therapy. Evidence-based non-hormonal options may be considered depending on the symptom.
Technology-based treatments address different targets and are not substitutes for a proper hormonal assessment.
Learn More →You do not need to diagnose yourself or select a device before contacting the clinic. The consultation is where symptoms, history and goals are reviewed so the appropriate next step can be determined.
Describe the symptoms, timing, triggers, life stage and how the concern affects your day-to-day life.
Dr. Maria Bleszynski can determine likely contributing factors and whether further evaluation is needed.
If treatment is appropriate, the clinic can discuss evidence-based and private wellness options suited to your individual situation.
Detailed answers make the page more useful for patients, search engines and Surrey Women’s Clinic’s future AI knowledge base.
Yes. The Menopause Society identifies hormone therapy as the most effective treatment for vasomotor symptoms in appropriate candidates.
Not everyone. Women with a uterus generally need endometrial protection when using systemic estrogen; women without a uterus may have different requirements.
No. Low-dose vaginal estrogen primarily targets local genitourinary tissue, while systemic therapy treats broader symptoms throughout the body.
No. Candidacy depends on age, timing, medical history, risk factors and the specific formulation and route.
There is no universal stop date. Duration should be individualized and periodically re-evaluated based on symptoms, benefits and risks.
Start with your concern rather than trying to choose the treatment yourself. A private consultation can help determine the cause, the appropriate care pathway and whether Explore Technologies or another option belongs in your plan.
This page provides general educational information and does not replace medical advice, diagnosis or treatment. Symptoms can have multiple causes. Treatment suitability varies by individual and is determined after clinical assessment.
Need help finding the clinic? Call 604-583-8337 for directions or general assistance.